chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Dysphagia, Headache, Pharyngeal swelling, Throat tightness
Clinical narrative: metallic taste in my mouth; slight tightening of my throat; my throat swelling worsened making it difficult to swallow; my throat swelling worsened making it difficult to swallow; slight headache; This is a spontaneous report from a contactable consumer (patient, self-reported). A 27-Year-old Female patient (age at vaccination: 27 year) received a dose of BNT162B2 (PFIZER-BIONTEC COVID-19 mRNA VACCINE, Solution for injection, lot number: EN6199 and expiry date was not reported), via an unspecified route of administration, in Arm Left, on 05Mar2021 at 13:30 PM, as a single dose for COVID-19 immunization. The patient was not pregnant at the time of vaccination. The patient's medical history included asthma, environmental allergies and known allergies of chickpeas, pet dander and dust mites (from an unknown date and unknown if ongoing). Concomitant medications included loratadine (CLARITINE); fluticasone propionate (FLONASE) and multivitamins (Vitamins not otherwise specified (NOS)) daily (taken for an unspecified indication, start and stop date were not reported). Patient had no other vaccine in four weeks. It was unknown if patient had COVID prior vaccination. The patient was not tested for covid post vaccination. On 05Mar2021 at 13:35 hours (5 minutes after injection), the experienced a metallic taste in her mouth and a slight tightening of her throat. While in observation, this persisted so she told a nurse and PA on site, they assured her that she was fine if she had no history of severe allergic reactions. She left observation at 25 minutes after injection. Upon driving home about 35-40 minutes later her throat swelling worsened making it difficult to swallow, the metallic taste persisted, and she also had slight headache. She used her Albuterol HFA rescue inhaler. The throat swelling and difficulty swallowing resolved shortly thereafter. The metallic taste and headache persist currently +2 hours after injection. The patient received unknown treatment for the events metallic taste in my mouth and slight headache. The outcome of the events metallic taste in my mouth and slight headache was not resolved and for all other events, it was resolved on 05Mar2021.  No follow-up attempts are needed. No further information is expected.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash
Clinical narrative: Started with a rash on chest the spread to abdominal area to the top of my thighs; I also experience a little throat tightening; Difficulty swallowing/Trouble swallowing; itched a little bit, the rash; feeling like something was stuck in her throat; This is a spontaneous report from a contactable consumer (patient) received from Medical Inquiry. A 49-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in arm left on 02Mar2021 at 14:30 as single dose for COVID-19 immunization. Medical history included rheumatoid arthritis (takes hydroxychloriquine 200 mg, two times daily), food allergy with garlic. Concomitant medication included hydroxychloroquine taken for RA (rheumatoid arthritis), start and stop date were not reported. The patient previously took hydrocodone and sulfa drugs and experienced allergies. The patient had not had COVID prior vaccination, and the test was not performed post vaccination. The patient did not receive any other vaccine within four weeks. On 04Mar2021, at 11:30, the patient stated that she developed a rash on left chest, it crossed down and over to the right abdomen and down to her thigh. She also experienced a little throat tightening and difficulty swallowing. She was now scheduled to get second shot on March 23 and wanted to be sure it is safe to do so and if she should take some medicine prior to it she had been unsuccessful reaching people to try and answer this. She had to go for my second Pfizer shot on Tuesday and she had been trying to get an answer. She could not get an answer from anybody. She also had a little trouble swallowing and took some Benadryl. The first 2 days after that she took it, twice a day and night, it lasted in a couple of days. It itched a little bit, the rash. Caller stated that she also had a sensation of feeling like something was stuck in her throat and had some trouble swallowing but these symptoms were gone the next morning. Caller would like to know if she should receive the second dose? Caller stated that she spoke to her HCP who instructed to call Pfizer for guidance. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events with drug Benadryl, steroid, and allergy medicines. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dysphagia, Oropharyngeal discomfort, Rash, Rash pruritic, Throat tightness
Clinical narrative: Started with a rash on chest the spread to abdominal area to the top of my thighs; I also experience a little throat tightening; Difficulty swallowing/Trouble swallowing; itched a little bit, the rash; feeling like something was stuck in her throat; This is a spontaneous report from a contactable consumer (patient) received from Medical Inquiry. A 49-years-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Batch/Lot Number: EN6202), via an unspecified route of administration, administered in arm left on 02Mar2021 at 14:30 as single dose for COVID-19 immunization. Medical history included rheumatoid arthritis (takes hydroxychloriquine 200 mg, two times daily), food allergy with garlic. Concomitant medication included hydroxychloroquine taken for RA (rheumatoid arthritis), start and stop date were not reported. The patient previously took hydrocodone and sulfa drugs and experienced allergies. The patient had not had COVID prior vaccination, and the test was not performed post vaccination. The patient did not receive any other vaccine within four weeks. On 04Mar2021, at 11:30, the patient stated that she developed a rash on left chest, it crossed down and over to the right abdomen and down to her thigh. She also experienced a little throat tightening and difficulty swallowing. She was now scheduled to get second shot on March 23 and wanted to be sure it is safe to do so and if she should take some medicine prior to it she had been unsuccessful reaching people to try and answer this. She had to go for my second Pfizer shot on Tuesday and she had been trying to get an answer. She could not get an answer from anybody. She also had a little trouble swallowing and took some Benadryl. The first 2 days after that she took it, twice a day and night, it lasted in a couple of days. It itched a little bit, the rash. Caller stated that she also had a sensation of feeling like something was stuck in her throat and had some trouble swallowing but these symptoms were gone the next morning. Caller would like to know if she should receive the second dose? Caller stated that she spoke to her HCP who instructed to call Pfizer for guidance. The adverse events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the events with drug Benadryl, steroid, and allergy medicines. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Blood glucose increased, Blood pressure measurement, Condition aggravated, Thyroid function test
Clinical narrative: Blood clot left leg development; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6200), intramuscular at the shoulder/upper arm on 19Feb2021 11:30 (at the age of 69-years-old) as second dose, single for COVID-19 immunization. Medical history included diabetes and hypertension from 2012 and ongoing, and hypothyroidism from 1980 and ongoing. Concomitant medications included metformin taken for diabetes from 2012 and ongoing; thyroid (ARMOUR THYROID) taken for hypothyroidism from 1980 and ongoing; clonidine taken for hypertension from 2019 and ongoing; and liothyronine sodium taken for hypothyroidism from 2015 and ongoing. The patient had no prior vaccinations. The patient previously received BNT16B2 (lot number: EL9265), intramuscular at the shoulder/upper arm on 29Jan2021 11:30 (at the age of 69-years-old) at first dose, single for COVID-19 immunization and experienced severe pain. The patient experienced blood clot left leg development on 08May2021. The event was reported as serious due to persistent/significant disability/incapacity and required physician office and emergency room visit. Therapeutic measure taken as a result of blood clot left leg included Eliquis. Outcome of the event was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021218434 same patient/drug, different dose/events
Age: 69.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Thrombosis
Clinical narrative: Blood clot left leg development; This is a spontaneous report from a contactable consumer (patient). A 69-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number: EN6200), intramuscular at the shoulder/upper arm on 19Feb2021 11:30 (at the age of 69-years-old) as second dose, single for COVID-19 immunization. Medical history included diabetes and hypertension from 2012 and ongoing, and hypothyroidism from 1980 and ongoing. Concomitant medications included metformin taken for diabetes from 2012 and ongoing; thyroid (ARMOUR THYROID) taken for hypothyroidism from 1980 and ongoing; clonidine taken for hypertension from 2019 and ongoing; and liothyronine sodium taken for hypothyroidism from 2015 and ongoing. The patient had no prior vaccinations. The patient previously received BNT16B2 (lot number: EL9265), intramuscular at the shoulder/upper arm on 29Jan2021 11:30 (at the age of 69-years-old) at first dose, single for COVID-19 immunization and experienced severe pain. The patient experienced blood clot left leg development on 08May2021. The event was reported as serious due to persistent/significant disability/incapacity and required physician office and emergency room visit. Therapeutic measure taken as a result of blood clot left leg included Eliquis. Outcome of the event was not recovered.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021218434 same patient/drug, different dose/events
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Glossodynia, Tongue blistering
Clinical narrative: purplish red circle/blister has formed on tongue; Sore tongue; This is a spontaneous report from a contactable reporter, patient. A 58-year-old non-pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6207) as a single dose, via unspecified route of administration in the right arm for COVID-19 immunisation on 16Mar2021 at 10:15. Medical history included high blood pressure. Concomitant medication included carvedilol (MANUFACTURE UNKNOWN) of 12.5 mg and verapamil (MANUFACTURE UNKNOWN) of 80 g for unknown indications. The patient did not have any allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Since the vaccination, the patient had not been tested for COVID-19.  On 16Mar2021 at 02:30PM the patient experienced sore tongue. On the second day (17Mar2021) tongue was only sore on the side the vaccine was received on (right), and a purplish red circle/blister has formed, the blister and soreness are still there 3 full days later, making it uncomfortable to eat or drink. It is reported that no treatment was received for adverse events. The clinical outcome of sore tongue, purplish red circle/blister has formed on tongue was not recovered at this time of report.    No follow-up attempts are possible. No further information is expected.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Cheilitis, Lymphadenopathy, Rash
Clinical narrative: Swollen lymph nodes in neck; rash on chin; This is a spontaneous report from a contactable consumer. A 60-year-old non-pregnant female patient received first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: unknown) via an unspecified route of administration in the Arm Left on 13Mar2021at 12:45 PM (at the age of  60-year-old) for COVID-19 Immunisation. Facility where the COVID-19 vaccine was administered was pharmacy or drug store. Medical history was reported as seasonal allergies, high blood pressure, high cholesterol. Concomitant medications were reported as CLARITAN-D, atorvastatin(MANUFACTURER UNKNOWN), propranolol(MANUFACTURER UNKNOWN), losartan(MANUFACTURER UNKNOWN) for unknown indication from unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not tested for COVID-19. Patient had not symptoms associated with COVID-19. The patient was not enrolled in clinical trial.  Information about ethnicity and race is reported. Patient did not have allergies to medications, food, or other product. On 15Mar2021 at 08:00 AM, the patient experienced swollen lymph nodes in neck 2 -5 days after injection rash on chin 2-5 days after injection and the clinical outcome of these events were recovering at the time of this report. The patient did not receive treatment for the events.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Lymphadenopathy, Rash
Clinical narrative: Swollen lymph nodes in neck; rash on chin; This is a spontaneous report from a contactable consumer. A 60-year-old non-pregnant female patient received first single dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; lot Number: unknown) via an unspecified route of administration in the Arm Left on 13Mar2021at 12:45 PM (at the age of  60-year-old) for COVID-19 Immunisation. Facility where the COVID-19 vaccine was administered was pharmacy or drug store. Medical history was reported as seasonal allergies, high blood pressure, high cholesterol. Concomitant medications were reported as CLARITAN-D, atorvastatin(MANUFACTURER UNKNOWN), propranolol(MANUFACTURER UNKNOWN), losartan(MANUFACTURER UNKNOWN) for unknown indication from unspecified date. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had not tested for COVID-19. Patient had not symptoms associated with COVID-19. The patient was not enrolled in clinical trial.  Information about ethnicity and race is reported. Patient did not have allergies to medications, food, or other product. On 15Mar2021 at 08:00 AM, the patient experienced swollen lymph nodes in neck 2 -5 days after injection rash on chin 2-5 days after injection and the clinical outcome of these events were recovering at the time of this report. The patient did not receive treatment for the events.  No follow-up attempts are possible; information about lot number cannot be obtained.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Aphasia, Asthenia, Dizziness, Dyspnoea, Dysstasia
Clinical narrative: neck pain; body aches; almost passed out; dizziness; weakness; difficulty breathing; feeling unwell; injection site pain; few chills; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE), dose 1 at vaccination age of 49-year-old via an unspecified route of administration in the left arm on 16Mar2021 18:00 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. Medical history included hypothyroidism, fibromyalgia, leaky gut/dysbiosis, recurring skin rashes/sinus infections, hypothyroidism (Hashimoto's), and known allergies to gluten and Dilaudid drugs. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included unspecified medications (too many to list here). The patient previously took benzoyl peroxide and thimerosal, but both were known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that 4 hours after the vaccine (16Mar2021 22:00), the she experienced dizziness, weakness, almost passed out, difficulty breathing, feeling unwell, injection site pain and few chills. It was reported that 14 hours after the vaccine (17Mar2021 08:00), the patient had dizziness, weakness, body aches, neck pain and chills. The patient did not received treatment for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The patient did not consider the events as serious. The outcome of the events was recovering.  Information on Lot/Batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Malaise, Paraesthesia
Clinical narrative: neck pain; body aches; almost passed out; dizziness; weakness; difficulty breathing; feeling unwell; injection site pain; few chills; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE), dose 1 at vaccination age of 49-year-old via an unspecified route of administration in the left arm on 16Mar2021 18:00 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. Medical history included hypothyroidism, fibromyalgia, leaky gut/dysbiosis, recurring skin rashes/sinus infections, hypothyroidism (Hashimoto's), and known allergies to gluten and Dilaudid drugs. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included unspecified medications (too many to list here). The patient previously took benzoyl peroxide and thimerosal, but both were known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that 4 hours after the vaccine (16Mar2021 22:00), the she experienced dizziness, weakness, almost passed out, difficulty breathing, feeling unwell, injection site pain and few chills. It was reported that 14 hours after the vaccine (17Mar2021 08:00), the patient had dizziness, weakness, body aches, neck pain and chills. The patient did not received treatment for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The patient did not consider the events as serious. The outcome of the events was recovering.  Information on Lot/Batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Asthenia, Chills, Dizziness, Dyspnoea, Malaise
Clinical narrative: neck pain; body aches; almost passed out; dizziness; weakness; difficulty breathing; feeling unwell; injection site pain; few chills; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE), dose 1 at vaccination age of 49-year-old via an unspecified route of administration in the left arm on 16Mar2021 18:00 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. Medical history included hypothyroidism, fibromyalgia, leaky gut/dysbiosis, recurring skin rashes/sinus infections, hypothyroidism (Hashimoto's), and known allergies to gluten and Dilaudid drugs. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included unspecified medications (too many to list here). The patient previously took benzoyl peroxide and thimerosal, but both were known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that 4 hours after the vaccine (16Mar2021 22:00), the she experienced dizziness, weakness, almost passed out, difficulty breathing, feeling unwell, injection site pain and few chills. It was reported that 14 hours after the vaccine (17Mar2021 08:00), the patient had dizziness, weakness, body aches, neck pain and chills. The patient did not received treatment for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The patient did not consider the events as serious. The outcome of the events was recovering.  Information on Lot/Batch number has been requested.
Age: 49.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Neck pain, Pain, Presyncope, Vaccination site pain
Clinical narrative: neck pain; body aches; almost passed out; dizziness; weakness; difficulty breathing; feeling unwell; injection site pain; few chills; This is a spontaneous report from a contactable consumer (patient). A 49-year-old non-pregnant female patient received bnt162b2 (BNT162B2 reported as PFIZER COVID-19 VACCINE), dose 1 at vaccination age of 49-year-old via an unspecified route of administration in the left arm on 16Mar2021 18:00 (Batch/Lot number was not reported) as 1st dose, single dose for covid-19 immunisation. Medical history included hypothyroidism, fibromyalgia, leaky gut/dysbiosis, recurring skin rashes/sinus infections, hypothyroidism (Hashimoto's), and known allergies to gluten and Dilaudid drugs. The patient was not diagnosed with COVID-19 prior to vaccination. Concomitant medications included unspecified medications (too many to list here). The patient previously took benzoyl peroxide and thimerosal, but both were known allergies. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient reported that 4 hours after the vaccine (16Mar2021 22:00), the she experienced dizziness, weakness, almost passed out, difficulty breathing, feeling unwell, injection site pain and few chills. It was reported that 14 hours after the vaccine (17Mar2021 08:00), the patient had dizziness, weakness, body aches, neck pain and chills. The patient did not received treatment for the adverse event. The patient has not been tested for COVID-19 since the vaccination. The patient did not consider the events as serious. The outcome of the events was recovering.  Information on Lot/Batch number has been requested.
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Immediate post-injection reaction
Clinical narrative: Almost immediate bright red rash all over hands - front and palms. looked like hands dipped in red paint.; This is spontaneous report from contactable consumer, the patient. A 60-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: LOT #EN6207) via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included was not reported. concomitant medications includes herbal supplement. The Patient did not have any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient experienced immediate bright red rash all over hands from front and palms. Looked like hands dipped in red paint on 18Mar2021 at 14:30. Adverse event result in Doctor or other healthcare professional office/clinic visit and no treatment was received for the event. The clinical outcome of the  red rash was recovering.  No follow-up attempts are needed. No further information is expected
Age: 60.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous
Clinical narrative: Almost immediate bright red rash all over hands - front and palms. looked like hands dipped in red paint.; This is spontaneous report from contactable consumer, the patient. A 60-years-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: LOT #EN6207) via an unspecified route of administration in the left arm on 18Mar2021 at 14:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. Medical history included was not reported. concomitant medications includes herbal supplement. The Patient did not have any allergies to medications, food, or other products. The patient had not received any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19, prior to vaccination. The patient had not tested positive for COVID-19 since the vaccination. The patient experienced immediate bright red rash all over hands from front and palms. Looked like hands dipped in red paint on 18Mar2021 at 14:30. Adverse event result in Doctor or other healthcare professional office/clinic visit and no treatment was received for the event. The clinical outcome of the  red rash was recovering.  No follow-up attempts are needed. No further information is expected
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Fatigue, Headache, Lymphadenopathy, Myalgia
Clinical narrative: Muscle pain; Low grade fever; Fatigue; headache; swollen lymph nodes; Hives; This is a spontaneous report received from a contactable other healthcare professional, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in her left arm on 26Feb2021 at 9:45AM (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypothyroidism. The patient past drug history included received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9810) via an unspecified route of administration in her left arm on 04Feb2021 at 9:30 AM as a single dose for COVID-19 immunisation. The patient has allergies to medication and food sensitivities, seasonal allergies, pollen, dust mold. The patient was diagnosed with COVID-19 prior to vaccination. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since having the vaccine, the patient was not tested positive for COVID-19. The patient concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) cataplex C (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), Vit-D (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) within two weeks of COVID-19 vaccination. On 27Feb2021, the patient experienced low grade fever, fatigue, pain joints/muscles, headache, swollen lymph nodes. head to toes hives. The therapeutic measures taken included benadryl (MANUFACTURER UNKNOWN) on an unknown dose after calling a doctor. But it was stopped due to an unknown side effect. Started Antronex which was further mentioned as tolerable during day but not at night. It was also mentioned that the same medicine was continued week three with no relief and later began 10 day/5 mg Prednisone (MANUFACTURER UNKNOWN) on 18Mar2021. The clinical outcome of events low grade fever, fatigue, headache, swollen lymph nodes were resolved and hives was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pyrexia, Urticaria
Clinical narrative: Muscle pain; Low grade fever; Fatigue; headache; swollen lymph nodes; Hives; This is a spontaneous report received from a contactable other healthcare professional, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in her left arm on 26Feb2021 at 9:45AM (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypothyroidism. The patient past drug history included received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9810) via an unspecified route of administration in her left arm on 04Feb2021 at 9:30 AM as a single dose for COVID-19 immunisation. The patient has allergies to medication and food sensitivities, seasonal allergies, pollen, dust mold. The patient was diagnosed with COVID-19 prior to vaccination. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since having the vaccine, the patient was not tested positive for COVID-19. The patient concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) cataplex C (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), Vit-D (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) within two weeks of COVID-19 vaccination. On 27Feb2021, the patient experienced low grade fever, fatigue, pain joints/muscles, headache, swollen lymph nodes. head to toes hives. The therapeutic measures taken included benadryl (MANUFACTURER UNKNOWN) on an unknown dose after calling a doctor. But it was stopped due to an unknown side effect. Started Antronex which was further mentioned as tolerable during day but not at night. It was also mentioned that the same medicine was continued week three with no relief and later began 10 day/5 mg Prednisone (MANUFACTURER UNKNOWN) on 18Mar2021. The clinical outcome of events low grade fever, fatigue, headache, swollen lymph nodes were resolved and hives was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Fatigue, Headache, Lymphadenopathy, Myalgia, Pyrexia
Clinical narrative: Muscle pain; Low grade fever; Fatigue; headache; swollen lymph nodes; Hives; This is a spontaneous report received from a contactable other healthcare professional, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in her left arm on 26Feb2021 at 9:45AM (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypothyroidism. The patient past drug history included received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9810) via an unspecified route of administration in her left arm on 04Feb2021 at 9:30 AM as a single dose for COVID-19 immunisation. The patient has allergies to medication and food sensitivities, seasonal allergies, pollen, dust mold. The patient was diagnosed with COVID-19 prior to vaccination. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since having the vaccine, the patient was not tested positive for COVID-19. The patient concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) cataplex C (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), Vit-D (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) within two weeks of COVID-19 vaccination. On 27Feb2021, the patient experienced low grade fever, fatigue, pain joints/muscles, headache, swollen lymph nodes. head to toes hives. The therapeutic measures taken included benadryl (MANUFACTURER UNKNOWN) on an unknown dose after calling a doctor. But it was stopped due to an unknown side effect. Started Antronex which was further mentioned as tolerable during day but not at night. It was also mentioned that the same medicine was continued week three with no relief and later began 10 day/5 mg Prednisone (MANUFACTURER UNKNOWN) on 18Mar2021. The clinical outcome of events low grade fever, fatigue, headache, swollen lymph nodes were resolved and hives was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Urticaria
Clinical narrative: Muscle pain; Low grade fever; Fatigue; headache; swollen lymph nodes; Hives; This is a spontaneous report received from a contactable other healthcare professional, the patient. A 59-year-old non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6198) via an unspecified route of administration in her left arm on 26Feb2021 at 9:45AM (at the age of 59-year-old) as a single dose for COVID-19 immunisation. The patient medical history included hypothyroidism. The patient past drug history included received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EM9810) via an unspecified route of administration in her left arm on 04Feb2021 at 9:30 AM as a single dose for COVID-19 immunisation. The patient has allergies to medication and food sensitivities, seasonal allergies, pollen, dust mold. The patient was diagnosed with COVID-19 prior to vaccination. The patient has not received any other vaccines within 4 weeks prior to the COVID-19 vaccine. Since having the vaccine, the patient was not tested positive for COVID-19. The patient concomitant medications included levothyroxine (MANUFACTURER UNKNOWN) cataplex C (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN), Vit-D (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) within two weeks of COVID-19 vaccination. On 27Feb2021, the patient experienced low grade fever, fatigue, pain joints/muscles, headache, swollen lymph nodes. head to toes hives. The therapeutic measures taken included benadryl (MANUFACTURER UNKNOWN) on an unknown dose after calling a doctor. But it was stopped due to an unknown side effect. Started Antronex which was further mentioned as tolerable during day but not at night. It was also mentioned that the same medicine was continued week three with no relief and later began 10 day/5 mg Prednisone (MANUFACTURER UNKNOWN) on 18Mar2021. The clinical outcome of events low grade fever, fatigue, headache, swollen lymph nodes were resolved and hives was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Tinnitus
Clinical narrative: Ear fullness / pain, severe tinnitus, hyperacusis.
Age: 42.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Ear discomfort, Ear pain, Hyperacusis, Tinnitus
Clinical narrative: Ear fullness / pain, severe tinnitus, hyperacusis.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Body temperature increased, Cough, Dehydration
Clinical narrative: cough and had clear and sticky stuff that looked like jelly fish coming out; diarrhea; fever 100F; Tired; Chills/ has the shivers; feels really "limpy", "blah"; This is a spontaneous report from a contactable consumer (patient).  An 88-year-old female consumer intramuscular BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 15Mar2021 at 11:00 at single dose in left arm for COVID-19 immunisation at the age of 88-year-old. Lot number EN6207, expiration date was 31Jul2021. Medical history included blood pressure high, arthritis. Historical vaccine included first dose of bnt162b2 on 22Feb2021 for covid-19 immunisation at the age of 88-year-old (1st dose, Lot: EM9809, Expiry date: 30Jun2021, Route: Intramuscular, Anatomical Location: Right arm). On 17Mar2021 at 03:45, the patient experienced cough and had clear and sticky stuff that looked like jelly fish coming out, diarrhea, fever 100F, Tired, Chills/ has the shivers, feels really limpy, blah (as reported). On 16Mar2021, body temperature was 100 and 99 Fahrenheit, Oxygen saturation 95-98%. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Diarrhoea, Feeling abnormal, Hypersomnia, Myalgia, Pain
Clinical narrative: cough and had clear and sticky stuff that looked like jelly fish coming out; diarrhea; fever 100F; Tired; Chills/ has the shivers; feels really "limpy", "blah"; This is a spontaneous report from a contactable consumer (patient).  An 88-year-old female consumer intramuscular BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 15Mar2021 at 11:00 at single dose in left arm for COVID-19 immunisation at the age of 88-year-old. Lot number EN6207, expiration date was 31Jul2021. Medical history included blood pressure high, arthritis. Historical vaccine included first dose of bnt162b2 on 22Feb2021 for covid-19 immunisation at the age of 88-year-old (1st dose, Lot: EM9809, Expiry date: 30Jun2021, Route: Intramuscular, Anatomical Location: Right arm). On 17Mar2021 at 03:45, the patient experienced cough and had clear and sticky stuff that looked like jelly fish coming out, diarrhea, fever 100F, Tired, Chills/ has the shivers, feels really limpy, blah (as reported). On 16Mar2021, body temperature was 100 and 99 Fahrenheit, Oxygen saturation 95-98%. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sputum abnormal, Weight decreased
Clinical narrative: cough and had clear and sticky stuff that looked like jelly fish coming out; diarrhea; fever 100F; Tired; Chills/ has the shivers; feels really "limpy", "blah"; This is a spontaneous report from a contactable consumer (patient).  An 88-year-old female consumer intramuscular BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 15Mar2021 at 11:00 at single dose in left arm for COVID-19 immunisation at the age of 88-year-old. Lot number EN6207, expiration date was 31Jul2021. Medical history included blood pressure high, arthritis. Historical vaccine included first dose of bnt162b2 on 22Feb2021 for covid-19 immunisation at the age of 88-year-old (1st dose, Lot: EM9809, Expiry date: 30Jun2021, Route: Intramuscular, Anatomical Location: Right arm). On 17Mar2021 at 03:45, the patient experienced cough and had clear and sticky stuff that looked like jelly fish coming out, diarrhea, fever 100F, Tired, Chills/ has the shivers, feels really limpy, blah (as reported). On 16Mar2021, body temperature was 100 and 99 Fahrenheit, Oxygen saturation 95-98%. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Fatigue, Feeling abnormal
Clinical narrative: cough and had clear and sticky stuff that looked like jelly fish coming out; diarrhea; fever 100F; Tired; Chills/ has the shivers; feels really "limpy", "blah"; This is a spontaneous report from a contactable consumer (patient).  An 88-year-old female consumer intramuscular BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 15Mar2021 at 11:00 at single dose in left arm for COVID-19 immunisation at the age of 88-year-old. Lot number EN6207, expiration date was 31Jul2021. Medical history included blood pressure high, arthritis. Historical vaccine included first dose of bnt162b2 on 22Feb2021 for covid-19 immunisation at the age of 88-year-old (1st dose, Lot: EM9809, Expiry date: 30Jun2021, Route: Intramuscular, Anatomical Location: Right arm). On 17Mar2021 at 03:45, the patient experienced cough and had clear and sticky stuff that looked like jelly fish coming out, diarrhea, fever 100F, Tired, Chills/ has the shivers, feels really limpy, blah (as reported). On 16Mar2021, body temperature was 100 and 99 Fahrenheit, Oxygen saturation 95-98%. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
Age: 88.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Oxygen saturation, Productive cough, Pyrexia
Clinical narrative: cough and had clear and sticky stuff that looked like jelly fish coming out; diarrhea; fever 100F; Tired; Chills/ has the shivers; feels really "limpy", "blah"; This is a spontaneous report from a contactable consumer (patient).  An 88-year-old female consumer intramuscular BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on 15Mar2021 at 11:00 at single dose in left arm for COVID-19 immunisation at the age of 88-year-old. Lot number EN6207, expiration date was 31Jul2021. Medical history included blood pressure high, arthritis. Historical vaccine included first dose of bnt162b2 on 22Feb2021 for covid-19 immunisation at the age of 88-year-old (1st dose, Lot: EM9809, Expiry date: 30Jun2021, Route: Intramuscular, Anatomical Location: Right arm). On 17Mar2021 at 03:45, the patient experienced cough and had clear and sticky stuff that looked like jelly fish coming out, diarrhea, fever 100F, Tired, Chills/ has the shivers, feels really limpy, blah (as reported). On 16Mar2021, body temperature was 100 and 99 Fahrenheit, Oxygen saturation 95-98%. The outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.
Age: 66.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Body temperature increased, Chills, Malaise
Clinical narrative: I'm thinking... I'm having covid; chills; body malaise; fever/100.4 temperature; worse in the evening Friday; I'm scared; feeling cold; This is a spontaneous report received from a contactable consumer (Patient). A 66-Year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER2613, expiration date date: Jul2021), via an unspecified route of administration in left arm on 18Mar2021 at 14:15 as single dose for COVID-19 immunization. Medical history included Gout. Concomitant medications included Febuxostat for uric acid. On 19Mar2021 at 01:00 pm (Friday) at lunch time, the patient felt cold and had chills, around lunch time, body malaise all over later in the day. The patient had fever around that time, which worsened in the evening of Friday. On Saturday in the morning, the patient stated that fever was a little bit better around lunchtime to the evening and the same thing happened on Sunday and Monday too. The patient stated that fever gets worse in the lunchtime also in the evenings. The patient stated that fever had been the same for the past 3 days. The patient stated that he felt ok in the morning and as It was only 9am in Hawaii, he doesn't know how he will feel today. The patient stated that in the first 2 to 3 days he was not sure if he really had a fever or not because he didn't had a thermometer. The patient stated that yesterday he had a fever of 101.4. The patient stated that he did not take any ibuprofen or Tylenol. The patient stated that he can always bear with it. The patient stated that he was scared to get the 2nd dose as it was scheduled on 08Apr2021. The patient stated that he has been healthy all this time and now after he got the shot, he was thinking that he had covid. The patient wanted to know whether this was normal and what he could do to make it better. The caller stated that he was bearing it for now. The patient did not receive any treatment medication for the events. The outcome of the event thinking that he had covid was unknown and not recovered for other events.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Body temperature, Chills, Condition aggravated, Feeling cold, Malaise
Clinical narrative: I'm thinking... I'm having covid; chills; body malaise; fever/100.4 temperature; worse in the evening Friday; I'm scared; feeling cold; This is a spontaneous report received from a contactable consumer (Patient). A 66-Year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER2613, expiration date date: Jul2021), via an unspecified route of administration in left arm on 18Mar2021 at 14:15 as single dose for COVID-19 immunization. Medical history included Gout. Concomitant medications included Febuxostat for uric acid. On 19Mar2021 at 01:00 pm (Friday) at lunch time, the patient felt cold and had chills, around lunch time, body malaise all over later in the day. The patient had fever around that time, which worsened in the evening of Friday. On Saturday in the morning, the patient stated that fever was a little bit better around lunchtime to the evening and the same thing happened on Sunday and Monday too. The patient stated that fever gets worse in the lunchtime also in the evenings. The patient stated that fever had been the same for the past 3 days. The patient stated that he felt ok in the morning and as It was only 9am in Hawaii, he doesn't know how he will feel today. The patient stated that in the first 2 to 3 days he was not sure if he really had a fever or not because he didn't had a thermometer. The patient stated that yesterday he had a fever of 101.4. The patient stated that he did not take any ibuprofen or Tylenol. The patient stated that he can always bear with it. The patient stated that he was scared to get the 2nd dose as it was scheduled on 08Apr2021. The patient stated that he has been healthy all this time and now after he got the shot, he was thinking that he had covid. The patient wanted to know whether this was normal and what he could do to make it better. The caller stated that he was bearing it for now. The patient did not receive any treatment medication for the events. The outcome of the event thinking that he had covid was unknown and not recovered for other events.   No follow-up attempts are needed. No further information is expected.
Age: 66.0
Sex: M
Vaccine: UNK, COVID19
Symptoms: Nervousness, Pyrexia, Suspected COVID-19
Clinical narrative: I'm thinking... I'm having covid; chills; body malaise; fever/100.4 temperature; worse in the evening Friday; I'm scared; feeling cold; This is a spontaneous report received from a contactable consumer (Patient). A 66-Year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: ER2613, expiration date date: Jul2021), via an unspecified route of administration in left arm on 18Mar2021 at 14:15 as single dose for COVID-19 immunization. Medical history included Gout. Concomitant medications included Febuxostat for uric acid. On 19Mar2021 at 01:00 pm (Friday) at lunch time, the patient felt cold and had chills, around lunch time, body malaise all over later in the day. The patient had fever around that time, which worsened in the evening of Friday. On Saturday in the morning, the patient stated that fever was a little bit better around lunchtime to the evening and the same thing happened on Sunday and Monday too. The patient stated that fever gets worse in the lunchtime also in the evenings. The patient stated that fever had been the same for the past 3 days. The patient stated that he felt ok in the morning and as It was only 9am in Hawaii, he doesn't know how he will feel today. The patient stated that in the first 2 to 3 days he was not sure if he really had a fever or not because he didn't had a thermometer. The patient stated that yesterday he had a fever of 101.4. The patient stated that he did not take any ibuprofen or Tylenol. The patient stated that he can always bear with it. The patient stated that he was scared to get the 2nd dose as it was scheduled on 08Apr2021. The patient stated that he has been healthy all this time and now after he got the shot, he was thinking that he had covid. The patient wanted to know whether this was normal and what he could do to make it better. The caller stated that he was bearing it for now. The patient did not receive any treatment medication for the events. The outcome of the event thinking that he had covid was unknown and not recovered for other events.   No follow-up attempts are needed. No further information is expected.